Chocorich (Cocoa Polyphenols)

Chocorich is a proprietary cocoa polyphenol extract containing high concentrations of flavan-3-ols like epicatechin and catechin. These compounds theoretically support mood through antioxidant mechanisms and potential modulation of neuroinflammatory pathways.

Origin & History

Chocorich is a branded cocoa polyphenol extract derived from cocoa seeds (Theobroma cacao), specifically from unfermented or low-fermentation varieties like Amazon Ecuador CCN51 clone. The extraction process involves mechanical shelling, infrared heating (100-110°C), defatting to <1% fat content, and hydroalcoholic extraction using ethanol:water (70:30) at 70°C, resulting in a micronized powder with 60-90% total polyphenol content.

Historical & Cultural Context

No historical or traditional medicine context is provided for Chocorich specifically, as it is a modern branded extract. While cocoa (Theobroma cacao) has general ethnobotanical use in Mesoamerican systems, this connection is not established in the research for this particular ingredient.

Health Benefits

• No clinical evidence available - the research dossier contains no human trials or RCTs specifically for Chocorich
• General cocoa polyphenol research exists but is not tied to this branded ingredient
• Contains high levels of flavan-3-ols which have theoretical antioxidant properties via free radical scavenging
• Standardized to contain epicatechin (200-500 mg/g) and procyanidins, compounds studied in other cocoa research
• Evidence quality: No clinical studies available for this specific branded ingredient

How It Works

Chocorich contains flavan-3-ols including epicatechin and catechin that may scavenge free radicals and reduce oxidative stress. These polyphenols theoretically modulate neuroinflammatory pathways by inhibiting NF-κB activation and reducing pro-inflammatory cytokine production. The compounds may also influence nitric oxide synthesis and endothelial function through eNOS pathway activation.

Scientific Research

The research dossier explicitly states that search results lack specific human clinical trials, RCTs, or meta-analyses for Chocorich by name. No PubMed PMIDs are available in the provided sources for branded studies. While general cocoa polyphenol research exists, no study design details, sample sizes, or outcomes are tied directly to this branded ingredient.

Clinical Summary

No human clinical trials have been conducted specifically on the Chocorich branded ingredient. The research dossier lacks randomized controlled trials or human studies demonstrating efficacy for mood support. While general cocoa polyphenol research exists in the literature, these studies cannot be attributed to Chocorich's specific formulation or concentration. The current evidence base is insufficient to support clinical claims for this proprietary extract.

Nutritional Profile

Chocorich is a standardized cocoa polyphenol extract derived from Theobroma cacao beans, primarily valued for its bioactive flavan-3-ol content rather than macronutrient contribution. Key bioactive compounds: Epicatechin (standardized 200–500 mg/g), representing the primary monomeric flavan-3-ol; Procyanidins (oligomeric and polymeric forms, including procyanidin B2, B5, and C1), typically comprising 40–60% of total polyphenol content; Catechin (lesser amounts relative to epicatechin); Theobromine (residual, typically 10–30 mg/g depending on extraction process); Caffeine (trace to low levels, generally <5 mg/g). Total polyphenol content is typically standardized to ≥500–600 mg GAE/g (gallic acid equivalents) by Folin-Ciocalteu assay. Minimal macronutrient contribution at typical serving doses (100–500 mg): negligible calories, fat (<1 g), protein (<0.5 g), and carbohydrates (<1 g). Mineral content is trace at extract-level dosing but may include residual potassium, magnesium, iron, zinc, copper, and manganese from the cacao matrix — quantities nutritionally insignificant at supplement doses. No significant vitamin content. Dietary fiber is negligible in a purified polyphenol extract. Bioavailability notes: Monomeric epicatechin has moderate oral bioavailability (peak plasma at ~1–2 hours, estimated absorption 20–30% of ingested dose), primarily absorbed in the small intestine and undergoing extensive phase II metabolism (glucuronidation, sulfation, methylation) to form conjugated metabolites. Oligomeric procyanidins (dimers/trimers) have substantially lower bioavailability (<5–10%) and are largely metabolized by colonic microbiota into smaller phenolic acids (e.g., 3-hydroxyphenylpropionic acid, protocatechuic acid, hippuric acid) which may contribute to systemic effects. Polymeric procyanidins (degree of polymerization >3) are poorly absorbed intact and exert primarily local gastrointestinal antioxidant effects or serve as substrates for gut microbial metabolism. Co-ingestion with carbohydrates or fats may modestly enhance absorption of monomeric flavanols. Matrix effects from the extraction and formulation process may influence polyphenol release and bioaccessibility.

Preparation & Dosage

No clinically studied dosage ranges are available for Chocorich as human trials are absent. The extract is standardized to >18% polyphenols (dry matter), containing catechin 40-100 mg/g, epicatechin 200-500 mg/g, procyanidin B1 5-20 mg/g, and B2 80-250 mg/g in powder form. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other polyphenol extracts, antioxidants, mood support ingredients, cardiovascular support compounds

Safety & Interactions

Safety data specific to Chocorich is not available due to lack of human studies. General cocoa polyphenol extracts may cause mild gastrointestinal upset, headaches, or caffeine-like effects in sensitive individuals. Potential interactions with blood-thinning medications may occur due to flavonoid content affecting platelet aggregation. Pregnancy and breastfeeding safety has not been established for this specific branded ingredient.